Peter Hillmen
Impact in
- Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research
- Hemoglobinopathies and Related Disorders
- Immunology top 0.1%
- Complement system in diseases
Papers in
- Genetics 270
- Chronic Lymphocytic Leukemia Research 265
- Blood disorders and treatments 4
- Immunology 107
- Complement system in diseases 106
- Co-authors
- Russell P. Rother (23 shared papers)Thomas J. Kipps (31 shared papers)Stephen John Richards (52 shared papers)Michael J. Hallek (18 shared papers)Emili Montserrat (12 shared papers)Lucio Luzzatto (20 shared papers)Michael J. Keating (13 shared papers)Monica Bessler (21 shared papers)
- Journals
- Blood (147 papers)British Journal of Haematology (45 papers)Leukemia (18 papers)Haematologica (15 papers)Journal of Clinical Oncology (13 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Peter Hillmen
383 papers receiving 36.5k citations
Peter Hillmen's Hit Papers
Peers
Comparison fields: 5 of 143
- Genetics 21.4k
- Immunology 7.7k
- Hematology 2.8k
- Pathology and Forensic Medicine 2.2k
- Emergency Medicine 421
Countries citing papers authored by Peter Hillmen
This map shows the geographic impact of Peter Hillmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hillmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hillmen more than expected).
Fields of papers citing papers by Peter Hillmen
This network shows the impact of papers produced by Peter Hillmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hillmen. The network helps show where Peter Hillmen may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Hillmen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 394 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines Hit paper breakdown → | 2008 | 2828 |
| 2 | Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia Hit paper breakdown → | 2014 | 1438 |
| 3 | Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia Hit paper breakdown → | 2014 | 1384 |
| 4 | The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin Hit paper breakdown → | 2005 | 1324 |
| 5 | Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia Hit paper breakdown → | 2015 | 1301 |
| 6 | iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL Hit paper breakdown → | 2018 | 1270 |
| 7 | The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Hit paper breakdown → | 2006 | 1040 |
| 8 | Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia Hit paper breakdown → | 2015 | 782 |
| 9 | 2002 | 776 | |
| 10 | Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia Hit paper breakdown → | 2018 | 765 |
| 11 | Natural History of Paroxysmal Nocturnal Hemoglobinuria Hit paper breakdown → | 1995 | 714 |
| 12 | 2007 | 571 | |
| 13 | Guidelines for the diagnosis and management of adult aplastic anaemia Hit paper breakdown → | 2015 | 554 |
| 14 | 2007 | 529 | |
| 15 | 2004 | 511 | |
| 16 | Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial Hit paper breakdown → | 2021 | 491 |
| 17 | Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2015 | 488 |
| 18 | 2010 | 476 | |
| 19 | 2007 | 462 | |
| 20 | 2008 | 459 |
About Peter Hillmen
Peter Hillmen is a scholar working on Genetics, Immunology, Hematology, Physiology and Oncology, having authored 394 papers that have together received 37.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (265 papers), Complement system in diseases (106 papers), Blood groups and transfusion (10 papers), Hematopoietic Stem Cell Transplantation (5 papers), Erythrocyte Function and Pathophysiology (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Pulmonary Hypertension Research and Treatments (4 papers) and Blood disorders and treatments (4 papers). The work is most often cited by research in Genetics (21.4k citations), Immunology (7.7k citations), Hematology (2.8k citations), Pathology and Forensic Medicine (2.2k citations) and Emergency Medicine (421 citations). Peter Hillmen has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Russell P. Rother, Thomas J. Kipps, Stephen John Richards, Michael J. Hallek, Emili Montserrat, Lucio Luzzatto, Michael J. Keating, Monica Bessler, Andy C. Rawstron and Daniel Catovsky. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Haematologica and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.